Surge
Surge utilizes high-dimensional immune system analysis and AI to revolutionize precision medicine. Their flagship product, PreCyte®, predicts post-operative complications, and their SurgeLab™ discovers immune biomarkers to transform healthcare pathways and optimize patient care.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: €7.5M
Date: 28-Mar-2024
Investors: Eurazeo, Kima, Teampact, MH Innov’, Boutique Venture, HCVC, 50 Partners Santé
Markets: Healthtech, AI, Biotechnology
HQ: San Francisco, California, United States
Founded: 2020
Website: https://www.surgehq.ai
LinkedIn: https://www.linkedin.com/company/surge-ai
Twitter: https://twitter.com/HelloSurgeAI
Facebook: https://www.facebook.com/HelloSurgeAI
Crunchbase: https://www.crunchbase.com/organization/surge-ai-b4ea
Leave a Comment
Comments
No comments yet.